文献速递细菌感染、耐药与抗菌药物

门诊退伍军人皮肤软组织感染的流行病学、处置与治疗

Epidemiology, Disposition, and Treatment of Ambulatory Veterans With Skin and Soft Tissue Infections.
PubMed 文献 · Clin Infect Dis · 2021-01-01

本研究回顾性分析了2005至2018年退伍军人门诊及急诊就诊的皮肤软组织感染(SSTI)病例,发现SSTI发病率从4.58/1000患者年降至3.27/1000患者年(P < .001)。急诊相比初级保健更少使用β-内酰胺类(32.5% vs 51.7%),更多使用抗MRSA药物(51.4% vs 35.1%),且引流率更高(8.1% vs 2.6%)。抗菌药物选择与指南依从性不佳,如24.9%的化脓性SSTI未覆盖MRSA,40.1%的非化脓性SSTI使用了抗MRSA药物。

要点

  • 门诊SSTI发病率呈下降趋势。
  • 急诊与初级保健在抗生素选择和引流操作上存在差异。
  • 抗MRSA药物使用与指南推荐不一致。

核心结论

  • 门诊SSTI发病率随时间下降。
  • SSTI治疗因就诊场所不同而异。
  • 抗MRSA药物使用与指南依从性差。

研究设计与样本

  • 回顾性队列研究,纳入2005年1月1日至2018年6月30日在急诊或门诊诊断为SSTI的退伍军人。
  • 共纳入1 740 992例次SSTI,涉及1 156 725名患者。
  • 使用Poisson回归模型分析SSTI发病率随时间的变化。

主要发现

  • SSTI发病率从2005年的4.58/1000患者年显著下降至2018年的3.27/1000患者年(P < .001)。
  • 急诊相比初级保健,β-内酰胺类处方率更低(32.5% vs 51.7%),抗MRSA治疗率更高(51.4% vs 35.1%)。
  • 急诊切开引流率为8.1%,初级保健为2.6%。
  • 24.9%的化脓性SSTI使用了无抗MRSA活性的抗生素方案。
  • 40.1%的非化脓性SSTI使用了抗MRSA抗生素。

关键数值与推荐

  • 化脓性SSTI中无抗MRSA活性的抗生素使用比例为24.9%。
  • 非化脓性SSTI中抗MRSA抗生素使用比例为40.1%。

临床怎么用

  • 门诊SSTI治疗需关注指南依从性,尤其是抗MRSA药物的合理使用。
  • 急诊与初级保健在SSTI处置上存在差异,应优化不同场景下的治疗策略。

局限性

  • 回顾性研究设计可能引入偏倚。
  • 未评估指南不依从对患者结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most skin and soft tissue infections (SSTIs) are managed in the outpatient setting, but data are lacking on treatment patterns outside the emergency department (ED). Available data suggest that there is poor adherence to SSTI treatment guidelines. METHODS: We conducted a retrospective cohort study of Veterans diagnosed with SSTIs in the ED or outpatient clinics from 1 January 2005 through 30 June 2018. The incidence of SSTIs over time was modeled using Poisson regression using robust standard errors. Antibiotic selection and incision and drainage (I&D) were described and compared between ambulatory settings. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotic use was compared to SSTI treatment guidelines. RESULTS: There were 1 740 992 incident SSTIs in 1 156 725 patients during the study period. The incidence of SSTIs significantly decreased from 4.58 per 1000 patient-years in 2005 to 3.27 per 1000 patient-years in 2018 (P < .001). There were lower rates of β-lactam prescribing (32.5% vs 51.7%) in the ED compared to primary care (PC), and higher rates of anti-MRSA therapy (51.4% vs 35.1%) in the ED compared to PC. The I&D rate in the ED was 8.1% compared to 2.6% in PC. Antibiotic regimens without MRSA activity were prescribed in 24.9% of purulent SSTIs. Anti-MRSA antibiotics were prescribed in 40.1% of nonpurulent SSTIs. CONCLUSIONS: We found a decrease in the incidence of SSTIs in the outpatient setting over time. Treatment of SSTIs varied depending on the presenting ambulatory location. There is poor adherence to guidelines in regard to use of anti-MRSA therapies. Further study is needed to understand the impact of guideline nonadherence on patient outcomes.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Rhoads JLW, Willson TM, Sutton JD, et al. Epidemiology, Disposition, and Treatment of Ambulatory Veterans With Skin and Soft Tissue Infections. Clin Infect Dis. 2021. PMID: 32047886. doi:10.1093/cid/ciaa133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。